Related Experiment Video
Updated: Apr 23, 2026
10:11
Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
Published on: September 27, 2014
38.2K
Modeling of HIV/AIDS dynamic evolution using non-homogeneous semi-markov process
1Department of Statistics, College of Science, Bahir Dar University, Bahir Dar, Ethiopia.
Springerplus
|October 4, 2014
Summary
This study models HIV/AIDS progression using age and CD4 counts, finding older patients and lower counts increase mortality risk. Interventions are crucial as patients tend towards worse health states without them.
Area of Science:
- Epidemiology
- Biostatistics
- Public Health
Background:
- HIV/AIDS remains a significant global health challenge.
- Antiretroviral Therapy (ART) has transformed HIV management.
- Understanding disease progression dynamics is crucial for effective patient care.
Purpose of the Study:
- To model HIV/AIDS disease progression in patients under ART.
- To investigate the influence of patient age on disease transitions.
- To utilize non-homogeneous semi-Markov processes for forecasting.
Main Methods:
- A cohort of 1456 HIV/AIDS patients under ART follow-up in Ethiopia was analyzed.
- Disease states were defined by CD4 cell counts: SI (>500), SII (349-500), SIII (199-350), SIV (≤200), and Death (D).
- Non-homogeneous semi-Markov processes were employed to model transitions, incorporating age as a covariate.
Main Results:
- Increasing age significantly elevates the probability of transitioning to the death state.
- Higher CD4 cell counts correlate with a decreased probability of mortality.
- The likelihood of remaining in the same disease state diminishes with advancing age.
- Patients are more prone to progressing to worse health states than improving, highlighting the need for interventions.
Conclusions:
- Age is a critical factor influencing HIV/AIDS progression and mortality risk.
- ART effectiveness can be enhanced by considering individual patient age and current disease status.
- Dynamic monitoring and timely interventions are essential for managing HIV/AIDS progression effectively.
Related Concept Videos
01:25Modeling with Differential Equations
311
Population dynamics can be described mathematically by considering the population size P(t) as a function of time. The rate of change of the population is then represented by the derivative of P(t). A simple assumption is that the rate of growth is proportional to the size of the population itself. This leads to an exponential growth model, where the population increases rapidly without bound. While this is a useful first approximation, it does not reflect realistic long-term...
311
01:10Retrovirus Life Cycles
42.8K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
42.8K
01:09Pharmacodynamic Models: Additive and Proportional Drug Effect Model
114
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
114
01:06Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
327
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
327
01:26Exponential Equations for Modeling Growth
457
Exponential models are essential for describing rapid, multiplicative changes in natural systems, such as population growth. When a population doubles at regular intervals, the process can be modeled using a suitable base. For instance, a bacterial culture that doubles every three hours follows the model n(t)=n0⋅2t/3, where n(t) is the population at the time t.A more general model uses the natural base e, especially for continuous growth. This takes the form n(t)=n0⋅ert, where r is...
457
01:27Pharmacodynamic Models: Overview
150
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
150